Study ID: TVP-1012/232
Study Title
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
Teva Identifier
- TVP-1012/232
ClinicalTrials.gov Identifier
- NCT00203060
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: Rasagiline Mesylate | Drug: placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 35 Years and older
Trial Duration
- 07/01/1997 - 07/01/2000
Phase
- Phase 3
Study Type
Interventional
